Literature DB >> 18323769

Social influences on the concept of fibromyalgia.

Harold Merskey1.   

Abstract

Despite relevant evidence of physical illness promoting fibromyalgia syndrome (FMS), some authors claim that it is a psychological illness, or due to "psychological amplification." Good evidence for such views is lacking. Selection processes lead to increased rates of psychological illness in general practice and in specialist practice. The physical distress of FMS can increase both anxiety and depression. Questionable research supported by the insurance industry has tended to provide negative and disparaging views of pain. Current imaging studies support the view that central effects connected with FMS relate to the processing of noxious stimulation more than affective disorder.

Entities:  

Mesh:

Year:  2008        PMID: 18323769     DOI: 10.1017/s1092852900026791

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


  5 in total

1.  Adjudicating fibromyalgia. Confusion, concerns and possible solutions.

Authors:  Ellen Nergård Thompson
Journal:  Pain Res Manag       Date:  2015 Jul-Aug       Impact factor: 3.037

2.  [Comorbid depression mediates the association of childhood/adolescent maltreatment and fibromyalgia syndrome. A study with patients from different clinical settings].

Authors:  M Kosseva; S Schild; R Wilhelm-Schwenk; W Biewer; W Häuser
Journal:  Schmerz       Date:  2010-09       Impact factor: 1.107

3.  The notion of a "whiplash culture": a review of the evidence.

Authors:  Michael T Haneline
Journal:  J Chiropr Med       Date:  2009-09

Review 4.  Controversies and challenges in fibromyalgia: a review and a proposal.

Authors:  Helen Cohen
Journal:  Ther Adv Musculoskelet Dis       Date:  2017-03-26       Impact factor: 5.346

5.  The Social Course of Fibromyalgia: Resisting Processes of Marginalisation.

Authors:  Nicole Brown
Journal:  Int J Environ Res Public Health       Date:  2021-12-29       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.